BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Compounded "semaglutide" is not FDA approved semaglutide.com FDA's Overreach on Compounded Peptides RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157 Banned: Key Facts on the Latest FDA Decision